Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 06 Feb 2019
At a glance
- Drugs Tisotumab-vedotin (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Head and neck cancer; Non-small cell lung cancer; Pancreatic cancer; Solid tumours; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms innovaTV 207
- Sponsors Seattle Genetics
- 07 Jun 2018 Status changed from not yet recruiting to recruiting.
- 26 Mar 2018 Status changed from planning to not yet recruiting.
- 08 Feb 2018 New trial record